Pharmacokinetics of piperacillin in subjects with various degrees of renal function (original) (raw)

Effect of piperacillin on tobramycin pharmacokinetics in patients with normal renal function

Antimicrobial Agents and Chemotherapy, 1983

Inhibition of Flucloxacillin Tubular Renal Secretion by Piperacillin

British Journal of Clinical Pharmacology, 2008

Population Pharmacokinetics of Piperacillin at Two Dose Levels: Influence of Nonlinear Pharmacokinetics on the Pharmacodynamic Profile

Daniele Ouellet

Antimicrobial Agents and Chemotherapy, 2012

View PDFchevron_right

Effect of concomitant administration of piperacillin on the dispositions of isepamicin and gentamicin in patients with end-stage renal disease

K. Heim-Duthoy

Antimicrobial Agents and Chemotherapy, 1992

View PDFchevron_right

Piperacillin concentration in relation to therapeutic range in critically ill patients – a prospective observational study

Lorenz Frey

Critical Care, 2016

View PDFchevron_right

Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysis

Eduardo Asín-prieto

Journal of Antimicrobial Chemotherapy, 2014

View PDFchevron_right

Does consistent piperacillin dosing result in consistent therapeutic concentrations in critically ill patients? A longitudinal study over an entire antibiotic course

Veronique Stove

International Journal of Antimicrobial Agents, 2014

View PDFchevron_right

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsis

Andrew Dalley

International Journal of Antimicrobial Agents, 2010

View PDFchevron_right

Comparative Evaluation of Piperacillin in Vitro

Timothy Cleary

Antimicrobial Agents and Chemotherapy, 1978

View PDFchevron_right

Predictive Factors of Piperacillin Exposure and the Impact on Target Attainment after Continuous Infusion Administration to Critically Ill Patients

Evelyn Shaw

Antibiotics

View PDFchevron_right

Comparative pharmacokinetics of azlocillin and piperacillin in normal adults

Anita Rudy

Antimicrobial Agents and Chemotherapy, 1986

View PDFchevron_right

Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy

Michael THY

Antimicrobial Agents and Chemotherapy, 2022

View PDFchevron_right

Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid

Fritz Soergel

Antimicrobial Agents and Chemotherapy, 1993

View PDFchevron_right

An improved micro-scale liquid-chromatographic assay for piperacillin in plasma and urine

Donald Jung

Clinical chemistry, 1984

View PDFchevron_right

Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children with Normal and Augmented Renal Clearance

Michael THY

Clinical pharmacokinetics, 2018

View PDFchevron_right

Steady-state pharmacokinetics and pharmacodynamics of piperacillin/tazobactam administered by prolonged infusion in hospitalised patients

matthew wack

International Journal of Antimicrobial Agents, 2009

View PDFchevron_right

Studies On Effect Of Piperine On Oral Bioavailability Of Ampicillin And Norfloxacin

Kunchithapatham Janakiraman

African Journal of Traditional, Complementary and Alternative Medicines, 2008

View PDFchevron_right

Are standard doses of piperacillin sufficient for critically ill patients with augmented creatinine clearance?

David Paterson

Critical Care, 2015

View PDFchevron_right

Determination of free extracellular concentrations of piperacillin by microdialysis

Teresa Dalla Costa

Journal of Pharmaceutical Sciences, 1996

View PDFchevron_right

Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal disease

K. Heim-Duthoy

Antimicrobial Agents and Chemotherapy, 1990

View PDFchevron_right

Daily serum piperacillin monitoring is advisable in critically ill patients

Alain V Durocher

International Journal of Antimicrobial Agents, 2010

View PDFchevron_right

Pharmacokinetics of piperacillin-tazobactam: intermittent dosing versus continuous infusion

Jorge Díaz

2005

View PDFchevron_right

In Vitro and in Vivo Determination of Piperacillin Metabolism in Humans

Claudia Generaux

Drug Metabolism and Disposition, 2006

View PDFchevron_right

Population Pharmacokinetic Model of Piperacillin in Critically Ill Patients and Describing Interethnic Variation Using External Validation

André de Oliveira Baldoni

Antibiotics, 2022

View PDFchevron_right

Pharmacokinetics of Piperacillin-Tazobactam in Anuric Intensive Care Patients during Continuous Venovenous Hemodialysis

Hartmut Derendorf, Thomas Ackermann

Antimicrobial Agents and Chemotherapy, 2002

View PDFchevron_right

Altered Pharmacokinetics of Piperacillin in Febrile Neutropenic Patients with Hematological Malignancy

Jeffrey Lipman

Antimicrobial Agents and Chemotherapy, 2014

View PDFchevron_right

Pharmacokinetic parameters of netilmicin and protective effect of piperacillin regarding nephrotoxicity caused by netilmicin

ARÁNZAZU ZARZUELO CASTAÑEDA

European Journal of Drug Metabolism and Pharmacokinetics, 1998

View PDFchevron_right

Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans

J. Garaud

Antimicrobial Agents and Chemotherapy, 1985

View PDFchevron_right

Altered pharmacokinetics of piperacillin in febrile neutropenic patients with haematological malignancy

Michael Roberts, Thomas Robertson

Antimicrobial Agents and Chemotherapy, 2014

View PDFchevron_right

The rate of antibiotic dosage adjustment in renal dysfunction

Fanak Fahimi

Iranian journal of pharmaceutical research : IJPR, 2012

View PDFchevron_right

Effect of different renal function on antibacterial effects of piperacillin againstPseudomonas aeruginosaevaluated via the hollow-fibre infection model and mechanism-based modelling

Phillip Bergen

Journal of Antimicrobial Chemotherapy, 2016

View PDFchevron_right

Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis

Boban Erovic

Journal of Antimicrobial Chemotherapy, 2005

View PDFchevron_right

Piperacillin penetration into tissue of critically ill patients with sepsis—Bolus versus continuous administration?

Thomas Robertson, Andrew Dalley

Critical Care Medicine, 2009

View PDFchevron_right

Comparison of piperacillin plasma concentrations in a prospective randomised trial of extended infusion versus intermittent bolus of piperacillin/tazobactam in paediatric patients

Tatchanapong Chongcharoenyanon

International Journal of Infectious Diseases, 2021

View PDFchevron_right

Impact of piperacillin/tazobactam on nephrotoxicity in patients with Gram-negative bacteraemia

Ronald Hall

International Journal of Antimicrobial Agents, 2018

View PDFchevron_right

Pharmacokinetics of piperacillin in subjects with various degrees of renal function (original) (raw)

Related papers